First HIV-positive to HIV-negative liver transplant raises intriguing questions for cure research
Efavirenz, but not dolutegravir, linked to neurological problems in children
Some antiretroviral regimens associated with pre-term birth and low birth weight
Breastfeeding with undetectable viral load: genuine uncertainty on risk should be communicated to women with HIV, say Swiss doctors
Dolutegravir brings faster viral suppression in late pregnancy
Progress against HIV in young people lags behind as Africa's youth population grows
Dolutegravir: update on infant neural tube defects from Botswana
